LANTHANUM CARBONATE | A206868 | INVAGEN PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Shire Development LLC et al v. InvaGen Pharmaceuticals, Inc. 3 patentsANDA 206868lanthanum carbonate | E.D.N.Y. | 2014-12-12 | Terminated 2015-01-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.25
per ea
Lowest NADAC/Unit
$3.00
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 76282047890LANTHANUM CARB 1,000 MG TB CHW | $3.25 | EA | Generic | — | 2026-06-17 |
| 69097093698LANTHANUM CARB 1,000 MG TB CHW | $3.25 | EA | Generic | — | 2026-06-17 |
| 76282047690LANTHANUM CARB 500 MG TAB CHEW | $3.00 | EA | Generic | — | 2026-06-17 |
| 69097093498LANTHANUM CARB 500 MG TAB CHEW | $3.00 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.